Historically, stocks have lagged the S&P 500 by a median ~4% over the 90 days after a high insider sell (n ≈ 9,950, 2021-2026). Past results don't predict the future. How we measure this ↗
CEO McGill W Brett sells 60,000 shares (60.0K) at $27.53 avg for $1,651,590.00; post-sale holdings 173.0K shares (-25.7%)
CEO McGill W Brett executed two separate sales totaling 60,000 shares (60.0K shares) for $1,651,590.00 on 2025-08-25, reducing his stake from 233.0K shares to 173.0K shares, a reduction of 25.7%. The sale occurred when the stock was trading near its 52-week high of $36.22 (current price $27.94 is -22.9% from that peak), and notably the company reported negative net income of $-52.1M in its latest quarter against $657.2M in quarterly revenue. The combination of a large percentage reduction in CEO holdings during the recovery portion of the stock's recent trading range (30-day change: +25.9%; 90-day change: +29.6%) coinciding with reported losses warrants investor attention to the company's earnings trajectory and any forward guidance.
Director Biumi Bonnie doubles HZO holdings, buying 1,000 shares at $23.37 on 2025-03-11; stock down 37.7% from 52-week high.
Director Biumi Bonnie purchased 1,000 shares of MarineMax at $23.37, doubling her post-transaction holdings to 2,000 shares from a prior 1,000 shares. The purchase occurs as the stock trades 37.7% below its 52-week high of $37.71 and down 24.5% over the preceding 30 days. Across her cross-ticker open-market history, this insider has achieved an average 90-day return of +14.5% on prior buys with a 100% win rate, though her prior buy at HZO on 2025-02-24 does not yet have measurable outcomes. The company trades at a P/E of 9.67 with trailing quarterly revenue of $468.5M and net income of $18.1M, positioning it as a capital-efficient business, though annual revenue growth has slowed to +1.5%.
Director Biumi Bonnie buys initial 1,000 HZO shares at $26.50; stock -29.6% from 52-week high
Biumi Bonnie, as a director of MarineMax, purchased 1,000 shares at $26.50 on 2025-02-24, establishing an initial position with zero prior holdings. The stock is currently trading at $26.54, near the transaction price, but down -29.6% from its 52-week high of $37.71 and down -13.3% over the preceding 30 days. MarineMax reports a P/E of 10.92 with recent quarterly revenue of $468.5M and net income of $18.1M, paired with modest annual growth of +1.5%. The director's cross-ticker track record shows 1 prior buy with a 100% 90-day win rate and average 90-day return of +14.5%. This buy occurs within a backdrop of recent weakness but lacks additional context (cluster activity, scheduled plan disclosure, or company-specific catalyst) to establish a clear signal of strategic conviction or opportunistic accumulation.
Add HZO to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
